Phenobarbital-digitoxin interaction in the guinea pig liver

Area of Science:

• Pharmacology
• Hepatology
• Drug Metabolism

Background:

• Phenobarbital is known to affect drug metabolism.
• Digitoxin is a cardiac glycoside with hepatic metabolism.
• Understanding drug-herb interactions is crucial for patient safety.

Purpose of the Study:

• To investigate the effect of phenobarbital pretreatment on the liver concentration of digitoxin and its metabolites.
• To elucidate the mechanisms underlying changes in digitoxin disposition following phenobarbital exposure.

Main Methods:

• Intraperitoneal administration of digitoxin to guinea pigs.
• Measurement of liver digitoxin and metabolite concentrations.
• Analysis of hepatic subcellular distribution.
• Chromatographic analysis of organic soluble compounds.
• Thin-layer gel filtration for protein binding assessment.

Main Results:

• Phenobarbital pretreatment increased initial liver uptake of digitoxin.
• No significant differences in hepatic subcellular distribution explained the increased liver concentration.
• Phenobarbital inhibited digitoxin biotransformation, as evidenced by chromatographic analysis.
• Digitoxin and metabolite binding to soluble liver proteins was ruled out.
• Decreased biotransformation correlated with increased liver uptake and decreased bile concentrations.

Conclusions:

• Phenobarbital pretreatment inhibits digitoxin biotransformation in guinea pigs.
• This inhibition leads to increased hepatic accumulation of digitoxin.
• The findings suggest a significant drug-drug interaction potential between phenobarbital and digitoxin.